• SOLUTIONS Prognosis
The Promise of Paxlovid
If Pfizer’s Covid-19 treatment is to help end the pandemic, more nations need rapid access
“When Pfizer lnc. Revealed the efficacy of its Covid pill last November, the excitement was palpable. Scientists hailed Paxlovid as a break through. World leaders raced to lock up supplies. But just three months into the rollout, optimism about the drug’s ability to help bring a swift end to the pandemic is waning, as fears mount that unequal distribution will exacerbate the challenge of getting the virus under control.”
Edited by : Cynthia Koons, Rebecca Penty, and Rick Schine , Page 32